Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001172665-08-000074
Filing Date
2008-04-14
Accepted
2008-04-14 15:19:12
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 k_master.htm 10-K 1340366
2 ex3_2.htm EX-3.2 66374
3 exhibit10-21.htm EX-10.21 215508
4 exhibit10-22.htm EX-10.22 200822
5 ex1023.htm EX-10.23 65836
6 exhibit_311.htm EX-31.1 5498
7 exhibit_312.htm EX-31.2 6287
8 exhibit_321.htm EX-32.1 3519
9 exhibit_322.htm EX-32.2 2804
  Complete submission text file 0001172665-08-000074.txt   1908667
Mailing Address 101 CONVENTION CENTER DRIVE SUITE 310 LAS VEGAS NV 89109
Business Address 101 CONVENTION CENTER DRIVE SUITE 310 LAS VEGAS NV 89109 702-735-7001
SAMARITAN PHARMACEUTICALS INC (Filer) CIK: 0001057377 (see all company filings)

EIN.: 880431538 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32287 | Film No.: 08754541
SIC: 8731 Services-Commercial Physical & Biological Research